Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.36 |
| ▸ | PRKDC | P78527 | 1/20 | 0.33 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.30 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.30 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.30 |
| ▸ | PIM1 | P11309 | 1/20 | 0.30 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.30 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.30 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.30 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26435056 | 0.96 | ALOX5 (0.35) | ALOX5PRKDCGGPS1MAPTSIRT2 | |
| SCHEMBL26435709 | 0.94 | ALOX5 (0.36) | ALOX5PRKDCMAPTSIRT2SIRT1 | |
| SCHEMBL26435569 | 0.93 | ALOX5 (0.37) | ALOX5PRKDCGGPS1PIM1CSNK2A2 | |
| SCHEMBL26435050 | 0.93 | ALOX5 (0.36) | ALOX5PRKDCMAPTSIRT2SIRT1 | |
| SCHEMBL26434991 | 0.91 | ALOX5 (0.37) | ALOX5PRKDCSIRT2SIRT1KDM4E | |
| SCHEMBL26435054 | 0.91 | ALOX5 (0.34) | ALOX5PRKDCSIRT2SIRT1PIM1 | |
| SCHEMBL26435652 | 0.91 | ALOX5 (0.38) | ALOX5PRKDCGGPS1MAPTSIRT2 | |
| SCHEMBL26435559 | 0.91 | ALOX5 (0.38) | ALOX5PRKDCGGPS1SIRT2SIRT1 | |
| SCHEMBL24303275 | 0.90 | ALOX5 (0.44) | ALOX5PRKDCGGPS1MAPTPIM1 | |
| SCHEMBL18505428 | 0.90 | ALOX5 (0.44) | ALOX5PRKDCGGPS1MAPTPIM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230320205-A1 | NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-10-05 | — | — | US | disclosed |
| US-20230320205-A1 | NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230320205-A1 | NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS | NOM1, MNS1, NOS1 | ALOX5 1266/4885PRKDC 3142/4885GGPS1 1604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.